Deferral of maternal isoniazid preventive therapy to early postpartum had no effect on infant tuberculosis acquisition in our trial population, regardless of the diagnostic test used.
Dr. Vidya Mave and colleagues concluded considerable intrahost mycobacterium tuberculosis mutation rates were present at recurrence among patients with diabetes mellitus.
Dr. Akshay Gupte and team found females were 7 times more likely to have restrictive spirometry pattern and 22 times more likely to have preserved ratio impaired spirometry, compared with men.
Check out the photo gallery from CIDI at the 2023 Union Conference on Lung Health.
CIDI was in Paris for The Union Conference on Lung Health 2023! Check out what CIDI faculty and Johns Hopkins India Partners spoke about at the sessions listed!
A novel trial is underway in Pune to provide evidence on how best to find people with recurrent Tuberculosis (TB), so that they can be quickly linked to care.
Safe Zindagi, an online portal funded by USAID and PEPFAR, provides HIV care and services to hard-to-reach populations in India.
USAID, with support of PEPFAR, set up Adolescent-Friendly Health Centers through its flagship program, ACCELERATE, led by Johns Hopkins University School of Medicine, to support 10-17-year-old HIV positive adolescents with comprehensive health care and services.
Interim results are “promising” and show that a short treatment regimen called “3HP” could pave the way in preventing TB.